IDO2 and central nervous system cancer: Unlike gliomas, both the paraganglioma and pheochromocytoma and the neuroblastoma groups presented an increased expression of IDO2 (Figure 1B), while IDHw GBM and neuroblastomas presented a higher expression of TDO2 compared to the brain cortex.